The Benefits Of Investing In Aviva plc

Royston Wild explains why investing in Aviva plc (LON: AV) could generate massive shareholder returns.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Today I am outlining why Aviva (LSE: AV) (NYSE: AV.US) could be considered an attractive addiavivation to any stocks portfolio.

Dividend growth poised to ignite

Aviva’s appeal for income hunters has taken a severe bashing in recent times, with the drop-down effect of the 2008/2009 banking crisis on earnings and the firm’s subsequent transformation plan having prompted payout cuts in each of the past two years.

But with its restructuring programme well underway and its earnings outlook having turned the corner — City analysts expect growth of 118% and 9% in 2014 and 2015 respectively — Aviva’s previous reputation as a generous dividend payer looks set to return with some vim.

Indeed, current forecasts point to an inflation-smashing 11% rise in the full-year payment this year, to 16.7p per share. And a further 16% rise to 19.4p is pencilled in for 2015.

Although this year’s figure creates a dividend yield of just 3.1% — falling short of the FTSE 100 forward average of 3.3%, as well as a corresponding reading of 4.4% for the complete life insurance sector — next year’s terrific rise drives the yield to a much-improved 3.6%.

Revving up the readies

And I believe that Aviva’s considerable cash-generative qualities should keep shareholder payouts rising at such an impressive clip well into the future.

The insurance powerhouse saw incoming cash remittances jump 7% during January-June to £612m, driven by surging new business volumes and ongoing streamlining work. And Aviva is working hard to raise its remittance ratio and plans to push this to 80%, up from 72% as of last year.

Furthermore, the business is also locked in an ongoing streamlining programme to further bolster the balance sheet, with high-profile divestments over the past year including the sale of its Aviva USA subsidiary last autumn as well as a string of European divisions. Indeed, just last week Aviva offloaded it stake in CxG Aviva to Novacaixagalicia Banco for £226m following a favourable legal decision in Spain.

As well as getting dividends moving in the right direction once more, the firm’s strong capital base is also being used bolster its transformation programme, which includes a greater emphasis on digital development, as well as allowing it to invest heavily in UK infrastructure.

Last December Aviva pledged to piggyback the British economic recovery by ploughing £500m into a vast array of domestic ‘bricks and mortar’ projects, and just last month bought a further 11.4MW worth of residential solar systems from Zouk Capital, Aviva’s second such purchase from the business.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Royston does not own shares in Aviva.

More on Investing Articles

Concept of two young professional men looking at a screen in a technological data centre
Investing Articles

If I’d put £5,000 in Nvidia stock at the start of 2024, here’s what I’d have now

Nvidia stock was a massive winner in 2023 as the AI chipmaker’s profits surged across the year. How has it…

Read more »

Light bulb with growing tree.
Investing Articles

3 top investment trusts that ‘green’ up my Stocks and Shares ISA

I’ll be buying more of these investment trusts for my Stocks and Shares ISA given the sustainable and stable returns…

Read more »

Investing Articles

8.6% or 7.2%? Does the Legal & General or Aviva dividend look better?

The Aviva dividend tempts our writer. But so does the payout from Legal & General. Here he explains why he'd…

Read more »

a couple embrace in front of their new home
Investing Articles

Are Persimmon shares a bargain hiding in plain sight?

Persimmon shares have struggled in 2024, so far. But today's trading update suggests sentiment in the housing market's already improving.

Read more »

Market Movers

Here’s why the Unilever share price is soaring after Q1 earnings

Stephen Wright isn’t surprised to see the Unilever share price rising as the company’s Q1 results show it’s executing on…

Read more »

Investing Articles

Barclays’ share price jumps 5% on Q1 news. Will it soon be too late to buy?

The Barclays share price has been having a great time this year, as a solid Q1 gives it another boost.…

Read more »

Young black colleagues high-fiving each other at work
Investing Articles

The AstraZeneca share price lifts 5% on a top-and-bottom earnings beat

The AstraZeneca share price reached £120 today and helped push the FTSE 100 higher. Would I still buy this flying…

Read more »

Young black woman using a mobile phone in a transport facility
Market Movers

Meta stock slumps 13% after poor results. Here’s what I’ll do

Jon Smith flags up the reasons behind the fall in the Meta stock price overnight, along with his take on…

Read more »